TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Active Biotech AB (publ)
Closing information (x1000 SEK)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
0
|
0
|
6,725 |
| Financial expenses |
535
|
58
|
154 |
| Earnings before taxes |
-58,372
|
-49,825
|
-32,245 |
| EBITDA |
-57,886
|
-49,782
|
-32,306 |
| Total assets |
51,005
|
56,804
|
32,155 |
| Current assets |
44,120
|
55,858
|
30,284 |
| Current liabilities |
12,062
|
9,904
|
9,353 |
| Equity capital |
34,511
|
46,674
|
22,113 |
| - share capital |
1,368
|
1,126
|
750 |
| Employees (average) |
9
|
8
|
10 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
67.7%
|
82.2%
|
68.8% |
| Turnover per employee |
0
|
0
|
672 |
| Profit as a percentage of turnover | -479.5% | ||
| Return on assets (ROA) |
-113.4%
|
-87.6%
|
-99.8% |
| Current ratio |
365.8%
|
564.0%
|
323.8% |
| Return on equity (ROE) |
-169.1%
|
-106.8%
|
-145.8% |
| Change turnover |
0
|
-6,725
|
-1,700 |
| Change turnover % |
-100%
|
-20% | |
| Chg. No. of employees |
1
|
-2
|
-2 |
| Chg. No. of employees % |
13%
|
-20%
|
-17% |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.